#ICCC

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced preliminary, unaudited sales results for the

2 months ago

#ICCC ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it received an Incomplete Letter from the United States

2 months ago

#ICCC ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

4 months ago

#ICCC ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 ImmuCell (Nasdaq: ICCC) will report unaudited financial results for the quarter ended September 30, 2025 after market close on Thursday, November 13, 2025. The company plans a conference call to review results on Friday, November 14, 2025 at 9:00 AM ET, accessible by dialing (844) 855-9502 (U.S.) or (412) 317-5499 (international). A teleconference replay will be available through November 21, 2025 using access code 7664668.The company anticipates no change to preliminary third-quarter sales disclosed on October 7, 2025 and expects to file its Form 10-Q after market close on November 13, 2025. An updated corporate presentation will be posted under the Investors tab at www.immucell.com after the market close on November 13, 2025.

4 months ago

#ICCC ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025

www.stocktitan.net/news/ICCC/immu-cell-to-a...

0 0 0 0

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef

5 months ago

#ICCC ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

Former IDEXX Senior VP Olivier te Boekhorst to Lead ImmuCell's Expansion in Animal Health Solutions ImmuCell Corporation selects Olivier te Boekhorst, former IDEXX Senior VP, as new CEO effective Nov 1. Receives stock options for 161.7K shares. Current CEO Brigham to serve as advisor.

5 months ago

#ICCC ImmuCell Announces Selection of its Next President and CEO

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

Phil Boyce

@philedboyce.bsky.social

6 months ago

You don’t get to run a comic con and purport to support artists while using AI slop for your promotional material. A con run by a con man. #ICCC

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

7 months ago

ImmuCell Q2 Profit Jumps as Margins Rise | The Motley Fool

#ICCC #6de8b1bb-c303-457a-b119-06a2220346c9 #data-news

Origin | Interest | Match

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

7 months ago

#ICCC #3cac269b-e870-4b9c-b9ce-368c2286f512 #earningscall-transcripts

Origin | Interest | Match

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

7 months ago

ImmuCell Posts 18% Gain in Q2 | The Motley Fool

#ICCC #17001472-eac9-49ed-8f61-5b3d84c22e9a #data-news

Origin | Interest | Match

0 0 0 0

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025 ImmuCell Corporation (Nasdaq: ICCC) reported strong financial results for Q2 2025, with product sales increasing 18% to $6.4 million compared to Q2 2024. The company achieved significant improvements in profitability, posting net income of $502,000 ($0.06 per share) in Q2 2025, compared to a net loss of $1.5 million in Q2 2024.Key financial metrics include gross margin improvement to 44% in Q2 2025 (up from 22% in Q2 2024), and cash position strengthening to $6.0 million as of June 30, 2025. The company has eliminated its order backlog and is building inventory for the peak selling season. Regarding Re-Tain®, ImmuCell has initiated Investigational Product use while reducing development expenses and exploring strategic options.The company's stockholders' equity increased to $29.9 million, and Adjusted EBITDA improved to $1.4 million for the quarter.

7 months ago

#ICCC ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

ImmuCell Secures Better Terms in $2.3M Debt Deal, Extends Payment Timeline to 2030 Animal health company reduces interest rates and eliminates $1.9M balloon payment through new Maine Community Bank loan. Strengthens financial position for cattle health products. Learn more.

7 months ago

#ICCC ImmuCell Announces Bank Debt Refinancing

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

ImmuCell Earnings: Animal Health Leader to Reveal Q2 2025 Financial Performance Animal health innovator ImmuCell sets Q2 earnings release for Aug 14, conference call Aug 15. Learn about dairy/beef cattle health products performance. Get details.

7 months ago

#ICCC ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025

www.stocktitan.net/news/ICCC/immu-cell-to-a...

0 0 0 0

ImmuCell Reports Record Sales Growth: Animal Health Leader Clears Backlog, Plans 33% Capacity Boost Animal health company achieves 18% sales growth, eliminates $3.4M order backlog, and plans expansion to $40M capacity. See growth strategy details.

8 months ago

#ICCC ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

ImmuCell CEO Announces 2026 Retirement: Inside the Strategic Leadership Transition Plan Longtime CEO Michael Brigham to step down in early 2026. Board launches search for successor with planned transition period. See leadership continuity strategy.

8 months ago

#ICCC ImmuCell Embarks on CEO Succession Planning Process

www.stocktitan.net/news/ICCC/immu-cell-emba...

0 0 0 0

ImmuCell Q1 Earnings Shatter Records: Sales Hit $8.1M as Net Income Soars from Loss to $1.4M Profit Animal health leader posts strongest quarter ever with 42% gross margin. Record-breaking performance across key metrics signals major turnaround. See full results.

10 months ago

#ICCC ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 ImmuCell Corporation (NASDAQ: ICCC) has announced it will release its unaudited financial results for Q1 2025 after market close on May 14, 2025. The company will host a conference call on May 15, 2025, at 9:00 AM ET to discuss the results. The company maintains its preliminary sales results disclosed on April 8, 2025, with no anticipated changes. The Q1 2025 Form 10-Q filing is expected on May 14, 2025.ImmuCell, focused on dairy and beef cattle health products, manufactures First Defense® for newborn calf immunity and is developing Re-Tain® for subclinical mastitis treatment in dairy cows. An updated Corporate Presentation will be available on the company's website after market close on May 14.

10 months ago

#ICCC ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

www.stocktitan.net/news/ICCC/immu-cell-to-a...

0 0 0 0

Brice Neihardt

@yoda2126.bsky.social

10 months ago

Tune in tonight for an #ICCC news desk! Live on our YouTube channel and Facebook page! 4pm PST/ 7pm EST. #VCN #Newsdesk

0 0 0 0

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 ImmuCell (ICCC) reported record-breaking preliminary sales results for Q1 2025, achieving $8.1 million in quarterly sales, an 11% increase from Q1 2024. The company's performance showed strong growth with six-month sales reaching $15.8 million (up 28%) and twelve-month sales hitting $27.3 million (up 28%) through March 31, 2025.The Q1 2025 results exceeded the previous record set in Q4 2024 by 4%, helping reduce the order backlog to $4.0 million from $4.4 million. Production output during Q1 2025 reached approximately 108% of the company's estimated $30 million annual capacity.Additionally, ImmuCell is initiating Investigational Product use of Re-Tain® through a controlled launch to test market acceptance. The company submitted its Non-Administrative New Animal Drug Application in January 2025, though approval remains pending facility inspections at their contract manufacturer.

11 months ago

#ICCC ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

fanthatracks.com.web.brid.gy

@fanthatracks.com.web.brid.gy

11 months ago

ICCC 2025: Harrison Davis attending Harrison Davis is heading to Nashville for ICCCon, 16th - 18th May 2025.

0 0 0 0

Revolutionary Antibiotic-Free Mastitis Treatment Enters Market Testing Phase Novel dairy cow treatment begins controlled launch phase while awaiting FDA approval. Zero milk discard requirements set to disrupt traditional antibiotic market. Full analysis inside.

11 months ago

#ICCC ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

www.stocktitan.net/news/ICCC/immu-cell-anno...

0 0 0 0

11 months ago

A map showing the number of participants from different countries.

The 3. #ICCC workshop on #Geodesy for #Climate Research has come to an end. Very happy about 250+ registered participants from almost 60 countries and 77% of presenters being early career scientists. #EDI

Thank you to all speakers, conveners, participants & the orga team!

@iag-ggos.bsky.social

2 0 0 0

Exploring steric sea level variability in the Eastern Tropical Atlantic Ocean: a three-decade study (1993–2022) - Scientific Reports Scientific Reports - Exploring steric sea level variability in the Eastern Tropical Atlantic Ocean: a three-decade study (1993–2022)

11 months ago

Very interesting presentation by @franckghomsi.bsky.social on steric sea level variability in the Eastern Tropical Atlantic Ocean today at the #ICCC workshop on #Geodesy for #Climate Research.

Check out the corresponding paper here:
www.nature.com/articles/s41...

3 0 0 0

11 months ago

Another presentation on #GNSS for #hydrology by Motahareh Esfandyari-Kaloukan (Univ. of Isfahan) highlighting the benefit of using the Hilbert-Huang Transform in the processing of the GNSS time series. #ICCC

0 0 0 0

11 months ago

Screenshot of a presentation slide showing drought-induced displacement time series.

Another interesting presentation from the University of. Montana given by Zachary Young on creating a GPS-based drought index. #ICCC

1 0 0 0

11 months ago

How did atmospheric rivers increase water storage in the Western U.S. resulting in a (temporary?) relief from the past drought in California? Exciting story-telling by Hilary Martens from the Univ. of Montana at the #ICCC workshop. Check out the related EOS article: eos.org/articles/cal...

1 0 2 0

11 months ago

Screenshot of a presentation slide showing a map of hydrometeorological observations in Africa

We continue our #ICCC workshop with the afternoon session and a presentation by Mengouna Xavier from University of Yaoundé I (Cameroon) on rain gauge observations and their applications.

2 0 1 0

11 months ago

Slide from Lone's presentation showing regional hydrological angular momentums in different river basins

Another presentation from @gfz.bsky.social given by Lone Stumpe on the El Nino impact on earth rotation showing that ENSO has a strong impact on interannual hydrological angular momentum variations, especially for the length-of-day component. #ICCC

0 0 0 0